Sabby Management, LLC Purple Biotech Ltd. Transaction History

Sabby Management, LLC

  • $130,000
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.39 - $4.15 $63,746 - $110,688
-26,672 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$2.45 - $4.3 $65,346 - $114,689
26,672 New
26,672 $105,000
Q3 2021

Nov 15, 2021
SELL
$4.4 - $5.59 $222,596 - $282,798
-50,590 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$3.75 - $6.72 $119,036 - $213,312
31,743 Added 168.42%
50,590 $247,000
Q1 2021

May 17, 2021
BUY
$3.93 - $6.99 $74,068 - $131,740
18,847 New
18,847 $78,000

Others Institutions Holding PPBT

# of Institutions
2
Shares Held
19.3K
Call Options Held
0
Put Options Held
0
View Full List

About PURPLE BIOTECH LTD.

PPBT Quotes by TradingView
  • Ticker PPBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,303,300
  • Market Cap $46.5M
  • Description
  • Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...
More about PPBT
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email